bluebird bio to Cut Ribbon on New Gene Therapy Factory in Durham, NC; Plans to Hire

bluebird bio, headquartered in Cambridge, Mass., announced it will have a ribbon-cutting ceremony at its new gene therapy factory in Durham, NC. The manufacturing plant will produce lentiviral vectors for its gene and cell therapies, including bb2121 and bb21217 for multiple myeloma and possibly LentiGlobin for transfusion-dependent beta-thalassemia (TDT) and sickle cell disease.